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Abstract: In the biosocial model of Cloninger, three major personality dimensions, novelty seeking (NS), harm 
avoidance (HA), and reward dependence (RD) are dependent on central monoaminergic systems, respectively 
dopaminergic, serotonergic, and noradrenergic. This study investigated the relationships between these major 
personality dimensions and growth hormone (GH) responses to both apomorphine and clo-nidine challenge tests 
in healthy subjects. GH responses to apomorphine were significantly correlated with NS when peak relative 
values were considered (r = 0.47, P = 0.03). HA and RD did not show any relationships with the endocrine 
responses. In contrast, no significant relationship existed between GH responses to clonidine and any of the three 
temperament dimensions. These results gave another support of the hypothesized link between NS and 
dopaminergic central neurotransmission. In contrast, the results did not confirm the association between RD and 
noradrenergic central neurotransmission, probably because RD is poorly validated. This partial confirmation 
might suggest that the link between personality traits and neurotransmission systems is probably indirect.  
Keywords: Novelty seeking; Reward dependence; TCI; Apomorphine; Clonidine 
1. Introduction 
Over the past decade, Cloninger and his colleagues have developed a biosocial model of personality based on 
four temperaments (novelty seeking, harm avoidance, reward dependence, and persistence) and three characters 
(self-directedness, cooperativeness and self-transcendence; Cloninger,  1986,  1987; Cloninger & Svrakic,  1997; 
Cloninger, Svrakic, & Przybeck,  1993). 
According to Cloninger et al. (1993) temperaments refer to automatic emotional responses to experiences which 
are moderately heritable and stable throughout life. In contrast, characters refer to self-concepts and individual 
differences in goals and values which are moderately influenced by sociocultural learning and mature in 
progressive steps. Briefly described, novelty seeking (NS) is defined as the tendency to respond actively to novel 
stimuli leading to pursuit of rewards and escape from punishment. Harm avoidance (HA) corresponds to the 
tendency toward an inhibitory response to signals of aversive stimuli that lead to avoidance of punishment and 
non-reward. Reward dependence (RD) is defined as the tendency for a positive response to signals of reward to 
maintain or resist behavioral extinction. Persistence (P) is described in terms of perseverance despite frustration 
and fatigue. Self-directedness (SD) refers to the ability of an individual to control, regulate and adapt his 
behavior to fit the situation in accord with individually chosen goals and values. Cooperativeness (C) is 
formulated to account for individual differences in identification with and acceptance of other people. Self-
transcendence (ST) is a character associated with spirituality, and refers generally to identification with 
everything conceived as essential and consequential parts of a unified whole. 
The Temperament and Character Inventory (TCI) is a 226-item self-questionnaire developed by Cloninger and 
his colleagues to assess the seven dimensions of personality (Cloninger, Przybeck, Svrakic, & Wetzel, 1994). 
The variances explained by the rotated factors after Promax rotation ranged from 4.4% to 2.0%, which is 17.7% 
to 8.0% of the total variance in the 25 factors (Cloninger et al., 1993). The dimensions of the TCI are related to 
those proposed by Zuckerman (Zuckerman & Cloninger, 1996), and more particularly NS correlated positively 
with Impulsive Sensation Seeking, HA positively with Neuroticism-Anxiety, and C negatively with Aggression-
Hostility. 
According to the biosocial model of Cloninger, monoamine neurotransmitter systems are considered as the bases 
of fundamental personality traits (Cloninger, 1986, 1987, 1988). Then, the three fundamental temperaments (i.e. 
NS, HA, and RD) have been associated to a specific central neurotransmitter: NS to low basal dopaminergic 
activity (low basal firing rates of dopaminergic neurons being associated with postsynaptic supersensitivity and 
higher NS score, and inversely higher dopaminergic baseline activity being associated with relative postsynaptic 
downregulation and lower NS score), HA to high serotonergic activity (high HA scores being related to high 5-
HT release from presynaptic neurons and with postsynaptic 5-HT receptor down-regulation), and RD to low 
basal noradrenergic activity (low basal firing rate of locus coeruleus being associated with increased postsynaptic 
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sensitivity to norepinephrine and higher score on RD, and at the other extreme, low postsynaptic sensitivity 
being associated with high noradrenergic basal level and lower RD score). 
Although this model has been criticized by several authors for its simplicity and its lack of theoretical bases 
(Eysenck, 1990; Gelder, 1987; Gray, 1987; Liebowitz, 1987; Zuckerman, 1988), many psychometric and 
neurobiological investigations have described results that contribute to the validation of this model (Cloninger, 
Przybeck, & Svrakic, 1991; Hansenne & Ansseau, 1999; Hansenne, Pitchot, Gonzalez Moreno, Machurot, 
Reggers, & Ansseau, 1997; Hennig, Toll, Schonlau, Rohrmann, & Netter, 2000; Mulder & Joyce, 1994; Ruegg 
et al., 1997; Svrakic, Przybeck, & Cloninger, 1991; Wiesbeck, Mauerer, Thome, Jacob, & Boening, 1995). 
The association between NS and dopaminergic function has been validated in several studies. Wiesbeck et al. 
(1995) reported a significant correlation between growth hormone (GH) response to apomorphine (a 
dopaminergic D2 agonist) and novelty seeking scores in a sample of alcohol dependent men. In contrast, harm 
avoidance and reward dependence were not related to the endocrine response. More recently, Gerra, Zaimovic, 
Timpano, Zambelli, Delsignore, and Brambilla (2000) have shown that NS scores correlate positively with D2 
postsynaptic receptor sensitivity assessed by the bromocriptine challenge test in a sample of healthy subjects. 
This result is in agreement with a recent study suggesting an association between dopamine D2 receptor binding 
and the human NS trait in the right insula cortex (Suhara et al., 2001). In contrast, several studies have not 
validated the theoretical relation between dopaminergic function and NS (Curtin, Walker, Peyrin, Soulier, 
Badan, & Schulz, 1997; Limson et al., 1991). 
Contradictory results are available concerning the relationship between reward dependence and noradrenergic 
function. Limson et al. (1991) found no relationship between the CSF norepinephrine metabolite 3-methoxy-4-
hydroxyphenylglycol (MHPG) and the reward dependence score. In contrast, two studies (Curtin et al., 1997; 
Garvey, Noyes, Cook, & Blum, 1996) recently reported a positive association between reward dependence and 
urinary MHPG. 
Hansenne and Ansseau (1998) reported no association between GH response to clonidine (a selective alpha-2 
adrenoreceptor agonist) and RD in a sample of depressed inpatients. Moreover, the authors did not find an 
association between GH response to apomorphine (a dopaminergic D2 agonist) and NS. Therefore, this study did 
not validate the hypothesized relationship between novelty seeking and reward dependence dimensions and 
respectively, the dopaminergic and noradrenergic systems. A major limitation of this study was the sample of 
depressed inpatients. Indeed, since blunted response to apomorphine and clonidine challenge tests are reported in 
depression (Ansseau et al., 1988; Matussek et al., 1980), the negative results could be linked to the limited range 
of GH response to pharmacological probes in depressed inpatients. Moreover, subscales of NS and RD were 
influenced by the affective state of depressed patients (Hansenne, Reggers, Pinto, Kjiri, Ajamieh, & Ansseau, 
1999). 
The aim of this study was to replicate the same methodology (Hansenne & Ansseau, 1998) in a sample of 
healthy subjects to explore if the negative results obtained in the depressed sample were related or not to the 
clinical status of the patients. If we find relations consistent with the Cloninger model, that means that the 
depressive status of the patients played a role in the production of negative results. Therefore, we investigated 
the relationship between GH response to challenge tests (apomorphine, and clonidine) and the main 
temperaments from the TCI in a sample of healthy subjects (NS, HA, RD). Apomorphine and clonidine tests 
could be considered as two interesting tools to investigate respectively, the dopaminergic and the noradrenergic 
systems. Indeed, apomorphine is an unselective dopamine receptor agonist unfolding its activity mainly at the 
postsynaptic D2 dopamine receptors. It stimulates GH secretion in humans through dopamine receptors in the 
hypothalamus (Lal, De La Vega, Sourkes, & Friesen, 1972), and has been applied in depression (Ansseau et al., 
1988; Pitchot, Hansenne, Gonzalez Moreno, & Ansseau, 1992). The fact that apomorphine acts on the D2 
receptor is of interest because Cloninger associated NS with dopaminergic D2 activity (Cloninger, 1986, 1988). 
On the other hand, clonidine is a selective alpha-2 adrenoreceptor agonist (Starke, 1981) which induces a GH 
secretion, and has been widely used in psychiatric patients especially in depression (Ansseau et al., 1988; 
Hansenne, Pitchot, Gonzalez Moreno, Von Frenckell, & Ansseau, 1992; Matussek et al., 1980). It has been 
demonstrated that GH response to clonidine may provide a selective reflection of postsynaptic alpha-2 
adrenoreceptor (Siever & Uhde, 1984). Indeed, in contrast to the presynaptic alpha-2 (autoreceptors) action of 
clonidine which induces feedback inhibition by norepinephrine on central norepinephrine cell firing and 
norepinephrine release, GH response to clonidine is mediated by postsynaptic alpha-2 adrenergic receptors in the 
hypothalamus. Based on the biological foundations of the Cloninger's model, positive relationships between NS 
and GH response to apomorphine as well as between RD and GH response to clonidine were expected. For a 
more complete investigation of the link between the temperaments and neurotransmission systems, the 
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relationship between serotonergic function and temperaments has been reported elsewhere (Hansenne & 
Ansseau, 1999; Hansenne et al., 1997). 
2. Methods 
2.1.  Subjects 
Forty experimentally naive healthy subjects (20 women and 20 men, mean age of 32.5 ±10.4 years) recruited 
among the staff of the University Hospital of Liège (Belgium) participated in the study. They were paid for their 
participation (10 000 BEF). They all underwent a medical interview to exclude psychiatric or somatic disorders. 
Moreover, all subjects had a Body Mass Index (BMI) comprised between 20 and 25 (Bray, 1978; Thomas, 
McKay, & Cutlip, 1976). The Ethical Committee of the University of Liège Medical School approved the 
protocol and all subjects gave their informed consent. 
2.2.   Temperament assessment 
The subjects completed a French version of the 226-item self-questionnaire TCI within the day following the 
challenge tests. Cloninger has recommended the translated version of the TCI used in the study. It has been 
performed by Téhérani and Lépine and validated by Pélissolo and Lépine (1997). The patients were asked to 
read each item carefully and to answer with a pencil all of them even if they were not completely sure of the 
answer. After the patients completed the questionnaire, one author (MH) checked if the items had all been filled. 
All patients filled 'false' for the validity item (I have lied a lot on this questionnaire). 
2.3.  Neuroendocrine challenges 
Clonidine and apomorphine tests were performed at 1-day intervals, both after an overnight fast using a 
procedure previously described (Ansseau et al., 1988). Due to the influence of estrogens on growth hormone 
secretion (Tulandi, Lal, & Guyda, 1987), we included only premenopausal women and the challenge tests were 
performed between the third and the twelfth day of the menstrual cycle. Briefly, at 08:00, a butterfly needle was 
inserted into a forearm vein. Blood samples of 10 ml were collected 20 min before and immediately before the 
injection of clonidine or apomorphine at 08:30. Successive blood samples were collected 20, 40, 60 and 120 min 
after the injection. Clonidine (0.15 mg), diluted in saline to obtain 20 ml, and apomorphine (0.5 mg), diluted in 
saline to obtain 0.5 ml, were injected respectively IV in 10 min and SC. Blood samples were immediately 
centrifuged, and plasma was frozen and kept at -18 °C until analysis. 
Growth hormone was measured with a double antibody radioimmunoassay with intra-assay and inter coefficients 
of variation of respectively, 13.3 ±4.7 and 14.8 ±9.6% and a detection limit of 0.1 mIU/ml. GH responses to 
clonidine and apomorphine were assessed by peak values following injection as well as by the area under the 
curve (AUC) situated between injection (t0) and the last blood sample (t120). Both measures were performed 
with absolute and relative values (absolute values minus baseline). Since absolute and relative values were 
highly correlated (r<0.97), only relative values (peak and AUC) were reported here. 
Several subjects were rejected from further analysis because their GH basal values (tO) or their GH values at t-
20 were higher than 13 mIU/ml. The exclusion of subjects with basal GH value greater than 13 mIU/ml was 
recommended by Laakmann (1990) who demonstrated that healthy volunteers with high GH basal value (called 
prestimulator subjects) responded significantly less to a noradrenergic challenge than healthy volunteers with 
low basal values. In consequence, the pharmacological assessment was not valid in subjects with high basal 
values. Moreover, this criterion was usually adopted by our group (Ansseau et al., 1988; Hansenne et al., 1992; 
Pitchot et al., 1992), as well as by other groups (Checkley, Slade, & Shur, 1981; Dinan & Barry, 1990; Meltzer 
et al., 1984; Siever et al., 1983; Tancer, Stein, & Uhde, 1993). According to these criteria, 19 (17 women) from 
the apomorphine challenge and 17 (13 woman) subjects from the clonidine challenge were rejected. 
2.4. Statistical analysis 
The statistical analyses were performed using Statistica (4.5) for Windows (Statsoft, 1993). The relationships 
between the temperaments from the TCI and GH response clonidine and apomorphine tests were assessed by 
Pearson's correlation coefficients. 
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3. Results 
The mean temperament scores among the 21 subjects included to apomorphine challenge were: NS = 17.8 (S.D. 
= 3.7), HA = 12.9 (S.D. = 5.7), and RD=13.7 (S.D. = 3.0). Their mean age was 31.5 (S.D. = 9.8). Their GH 
relative peak values after apomorphine ranged from 0.07 to 53.6 mIU/ml (mean value: 15.6, S.D. = 15.4). The 
AUC values ranged from 04 to 2508.5 mIU min/ml (mean value = 814.4, S.D. = 780.6). The mean temperaments 
scores among the 23 subjects included to clonidine challenge were: NS = 16.8 (S.D. = 3.7), HA = 13.5 (S.D. = 
5.7), and RD = 13.8 (S.D. = 3.3). Their mean age was 32.9 (S.D. = 10.1). GH relative peak values after clonidine 
ranged from 0.03 to 60.52 mlU/ml (mean value = 18.2, S.D. = 18.2). The AUC values ranged from -131.6 to 
4396.4 mIU min/ml (mean value= 1135.2, S.D. = 1271.9). 
Table 1:  Pearson correlation coefficients (r) and probability values (P) between growth hormone (GH) 
response to apomorphine and clonidine tests (AUC and peak relative values) and the personality dimensions 
 Novelty seeking Harm avoidance Reward dependence 
GH response to Apomorphine    
Peak values r = 0.47; P = 0.03 r = -0.34;P = 0.13 r=-0.18;P = 0.43 
AUC
a
 values r = 0.40; P = 0.075 r = -0.35;P = 0.11 r = 0.21;P = 0.34 
GH response to Clonidine    
Peak values r = -0.03;P = 0.89 r = 0.30;P = 0.17 r = 0.23; P = 0.28 
AUC
a
 values r = -0.04; P = 0.82 r = 0.27;P = 0.19 r = 0.25;P = 0.25 
a AUC, area under the curve. 
 
Fig. 1: Correlation between growth hormone (GH) responses to apomorphine (peak relative values) and novelty 
seeking (NS) scores from the Temperament and Character Inventory (TCI) in healthy subjects. 
 
Pearson correlation coefficients and probability values are presented in Table 1. GH responses to apomorphine 
were significantly correlated with NS when peak relative values were considered (r = 0.47, P = 0.03; Fig. 1). 
When considering AUC values, the correlation did not reach the statistical level of significance (r = 0.40, P = 
0.075). HA and RD did not show any relationships with the endocrine responses. In contrast, no significant 
relationship existed between GH responses to clonidine and any of the three temperament dimensions. 
4. Discussion 
The main finding of this study is a positive correlation between NS and dopaminergic activity assessed by GH 
response to apomorphine in healthy subjects. Since apomorphine stimulates GH secretion via dopaminergic D2 
postsynaptic receptors located in the hypothalamus, this indicates that NS is related to D2 postsynaptic receptor 
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sensitivity, and consecutively related to low dopaminergic activity. It should be noted however that the 
assumption of decrease presynaptic dopaminergic secretion is more inferential, because the study has not 
examined the relationship between dopaminergic basal level and response to apomorphine challenge. 
Nevertheless, the present result supports the theory proposed by Cloninger concerning the link between NS and 
dopamine (Cloninger, 1986, 1987), and is in agreement with most of the data in the literature. 
Indeed, with a similar methodology, Wiesbeck et al. (1995) reported a significant correlation between GH 
response to apomorphine challenge test and NS among alcoholic subjects. Moreover, Gerra et al. (2000) found a 
significant direct correlation between NS and bromocriptine-stimulated GH values, and an inverse relationship 
between NS and bromocriptine-stimulated prolactin values. The authors conclude that NS scores correlate 
positively with D2 postsynaptic receptor sensitivity and, therefore, with decreased presynaptic dopaminergic 
secretion. However, Hansenne and Ansseau (1998) did not observe the relationship between NS and 
dopaminergic responses in a sample of depressed inpatients. This discrepancy may be explained by the fact that 
the latter study assesses the relationship between NS and dopaminergic activity among depressed patients and 
that dopaminergic disturbances associated with depression may alter the biological correlates of temperament 
traits. Therefore, the present relationship between GH response to apomorphine and NS among healthy 
volunteers is more valid. 
However, other negative results were published concerning the relationship between NS dimension and central 
dopaminergic neurotransmission. Limson et al. (1991) did not find any association between the concentration of 
cerebrospinal fluid (CSF) homovanillic acid (HVA) and NS scores in alcohol dependent men. Similar negative 
results were reported in normal subjects (Curtin et al., 1997). These negative results obtained with metabolite 
data (e.g. HVA) could suggest that the hypothesized association between basal level and receptor sensitivity is 
not valid. Moreover, recent genetic studies support partially the relationship between NS and dopamine. Whereas 
some studies have demonstrated that the D4 dopamine receptor gene is associated with NS (Benjamin, Li, 
Patterson, Greenberg, Murphy, & Hamer; 1996; Benjamin et al., 2000; Ebstein et al., 1996), others are less 
conclusive (Samochowiec et al., 2001). 
In this present study, RD scores are not correlated with noradrenergic activity, as assessed by the GH response to 
clonidine. This result does not confirm the link between RD and the noradrenergic system postulated by 
Cloninger (1986, 1987), and is in contrast with those reported by Gerra et al. (2000) who found a positive 
correlation between RD scores and GH response to clonidine, but replicate the results of a previous study 
(Hansenne & Ansseau, 1998). The discrepancy between the present negative finding and the Gerra's et al. results 
could depend on several factors. First, we used a unique dosage of clonidine (0.15 mg), whereas Gerra et al. 
injected a weight-related dosage of 2 µg clonidine per kg body weight. The choice of a unique dose of clonidine 
was made according to the fact that the BMI of our patients were within the normal ranges according to the 
monogram provided by Thomas et al. (1976) and Bray (1978). Second, the blood samples were not collected at 
the same times (0, 20, 40, 60 and 120 min in our study as compared to 0, 15, 30, 45, 60 and 90 min in the Gerra 
et al. study), which could induce different AUC and peak values. Third, gender was not similar in the two 
studies: whereas our study was conducted in both sexes, Gerra's et al. study included only men. 
Nevertheless, the link between RD and noradrenergic activity is far from clear. Whereas some studies report a 
positive association between RD and noradrenergic activity assessed by urinary noradrenergic metabolite 3-
methoxy-4-hydroxyphenylglycol (MHPG) (Curtin et al., 1997; Garvey et al., 1996), Limson et al. (1991) found 
no relationship between the CSF MHPG and reward dependence score. Moreover, Gerra et al. (2000) reported a 
significant inverse correlation between RD and the dopaminergic suppression of PRL during the bromocriptine 
challenge, suggesting that dopaminergic function may also influence this temperament trait. Finally, Tancer, 
Ranc, and Golden (1994) found a negative correlation between the RD dimension and GH peaks to clonidine test 
in healthy subjects. 
However, given the complexity of the central neurotransmitter systems, these results cannot be considered as 
definitive evidence against a relationship between noradrenergic activity and the RD dimension defined in the 
biosocial model of Cloninger (1986, 1987). Indeed, if neuroendocrine strategy constitutes a relevant index of 
central neurotransmission, it exhibits limitations. Clonidine stimulates GH secretion via noradrenergic alpha-2 
postsynaptic receptors located in the hypothalamus. It is however postulated that GH response assessed the 
sensitivity of these postsynaptic receptors. Based on the model of Cloninger, higher postsynaptic activity 
associated with low noradrenergic basal level, and in consequence higher RD score. Consequently, the negative 
results of this study must be carefully interpreted and are not simply transferable to the whole noradrenergic 
system. 
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The absence of a relationship between GH response to clonidine and the RD scale could also suggest that RD is 
a bad scale, even after persistence has been eliminated in the new version. Indeed, RD is very heterogeneous and 
has a low internal consistency (Cloninger et al., 1991). There are several reason for this. RD has fewer items than 
NS and HA, and the two subscales with the lower alphas (RD1 and RD4) have only five items. Moreover, the 
variances of all the RD subscales tend to be smaller. These problems will perhaps be solved with the new version 
of the TCI (TCI-R) which contains four subscales for RD, including a newer openness to warm communication 
subscale (10 items). 
Before concluding, it is important to underline an important limitation of this study. The two sexes are studied 
together, whereas hormone and temperament differences were shown. Indeed, HA and RD scales were higher in 
women than men (Hansenne, Le Bon, Gauthier, & Ansseau, 2001; Zohar, Lev-Ari, Benjamin, Ebstein, 
Lichtenberg, & Osher, 2001). In contrast NS was not different between men and women. In addition, hormone 
basal levels were different between men and women. For the apomorphine test, 17 women of 20 had a basal GH 
level higher than 13 mIU/ml. This difference can be explain by the effects of stress, contraception and estrogen. 
Consequently, it would be preferable to compute the relationship for both sexes separately. However, such 
analyses were not possible because of the low number of subjects. 
In conclusion, this study confirms the relationship between the dopaminergic system and the NS dimension from 
the model proposed by Cloninger (1986, 1987). However, the results do not validate the hypothesized 
relationship between the RD dimension and the noradrenergic system, but, according to the restrictions 
mentioned above, these data could not be considered as definitive evidence against the association between RD 
and specific neurotransmitter substrates. 
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